Comment | Published:

Drug discovery

A jump-start for electroceuticals

Nature volume 496, pages 159161 (11 April 2013) | Download Citation

  • A Correction to this article was published on 17 April 2013

Kristoffer Famm and colleagues unveil a multidisciplinary initiative to develop medicines that use electrical impulses to modulate the body's neural circuits.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    , , , & Principles of Neural Science 5th edn (McGraw Hill Professional, 2012).

  2. 2.

    et al. Arthritis Rheum. 64 (suppl.), abstr. 451 (2012).

  3. 3.

    , & Nature Neurosci. 14, 351–355 (2011).

  4. 4.

    et al. Nature 451, 61–64 (2008).

  5. 5.

    & J. Exp. Med. 209, 1057–1068 (2012).

  6. 6.

    & Sci. Transl. Med. 5, 177ps5 (2013).

  7. 7.

    , , , & PLoS ONE 7, 34292 (2012).

  8. 8.

    & Angew. Chem. Int. Ed. 51, 11700–11721 (2012).

  9. 9.

    et al. ACS Nano 7, 1850–1866 (2013).

  10. 10.

    , , , & Nature Meth. 9, 585–587 (2012).

Download references

Author information


  1. Kristoffer Famm is vice-president of bioelectronics research and development at GlaxoSmithKline, Brentford TW8 9GS, UK.

    • Kristoffer Famm
  2. Brian Litt is a professor in the Departments of Neurology and Bioengineering at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

    • Brian Litt
  3. Kevin J. Tracey is president of the Feinstein Institute for Medical Research, Manhasset, New York 11030, USA.

    • Kevin J. Tracey
  4. Edward S. Boyden is associate professor of synthetic neurobiology in the Departments of Biological Engineering and Brain and Cognitive Sciences at the Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.

    • Edward S. Boyden
  5. Moncef Slaoui is chairman of Global R&D and Vaccines at GlaxoSmithKline, Brentford TW8 9GS, UK.

    • Moncef Slaoui


  1. Search for Kristoffer Famm in:

  2. Search for Brian Litt in:

  3. Search for Kevin J. Tracey in:

  4. Search for Edward S. Boyden in:

  5. Search for Moncef Slaoui in:

Competing interests

B.L. has licensed intellectual property (IP) to and holds stock in NeuroPace. He has also licensed IP to and consults for mc10, Inc. K.J.T. is the co-founder of SetPoint Medical and is the inventor on patents around vagus nerve stimulation and the inflammatory reflex. E.S.B. receives funding through the MIT Media Lab from numerous companies (see, has consulted for GlaxoSmithKline and Medtronic, is a co-founder of Eos Neuroscience and an inventor on numerous neurotechnology patents (owned by MIT).

Corresponding author

Correspondence to Kristoffer Famm.

About this article

Publication history



Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing